SPP1 and Alzheimer disease: Therefore, we speculate that elevated OPN plasma levels in the initial stages of AD may contribute to the progression of cognitive decline, although the exact role of OPN and its underlying mechanism as a key proinflammatory cytokine in AD is not understood.